EHANG HOLDINGS LTD-SPS ADR (EH)

US26853E1029 - ADR

15.01  +0.99 (+7.06%)

After market: 15.13 +0.12 (+0.8%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EH. EH was compared to 65 industry peers in the Aerospace & Defense industry. The financial health of EH is average, but there are quite some concerns on its profitability. EH shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

EH had negative earnings in the past year.
EH had negative earnings in each of the past 5 years.
In the past 5 years EH always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -46.91%, EH is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
EH has a worse Return On Equity (-130.61%) than 78.46% of its industry peers.
Industry RankSector Rank
ROA -46.91%
ROE -130.61%
ROIC N/A
ROA(3y)-56.95%
ROA(5y)-41.16%
ROE(3y)-166.55%
ROE(5y)-111.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EH's Gross Margin of 63.27% is amongst the best of the industry. EH outperforms 96.92% of its industry peers.
In the last couple of years the Gross Margin of EH has grown nicely.
The Profit Margin and Operating Margin are not available for EH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.85%
GM growth 5Y4.79%

4

2. Health

2.1 Basic Checks

EH does not have a ROIC to compare to the WACC, probably because it is not profitable.
EH has more shares outstanding than it did 1 year ago.
EH has more shares outstanding than it did 5 years ago.
EH has a better debt/assets ratio than last year.

2.2 Solvency

EH has an Altman-Z score of 5.08. This indicates that EH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.08, EH is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
EH has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
EH has a Debt to Equity ratio of 0.26. This is in the better half of the industry: EH outperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 5.08
ROIC/WACCN/A
WACC7.97%

2.3 Liquidity

A Current Ratio of 1.97 indicates that EH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.97, EH is in line with its industry, outperforming 47.69% of the companies in the same industry.
EH has a Quick Ratio of 1.69. This is a normal value and indicates that EH is financially healthy and should not expect problems in meeting its short term obligations.
EH has a better Quick ratio (1.69) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.69

7

3. Growth

3.1 Past

The earnings per share for EH have decreased strongly by -15.94% in the last year.
The Revenue has grown by 47.84% in the past year. This is a very strong growth!
The Revenue has been growing by 78.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.33%
Revenue 1Y (TTM)47.84%
Revenue growth 3Y78.44%
Revenue growth 5YN/A
Sales Q2Q%365.53%

3.2 Future

EH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.54% yearly.
EH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.91% yearly.
EPS Next Y-551.53%
EPS Next 2Y-226.55%
EPS Next 3Y-121.71%
EPS Next 5Y33.54%
Revenue Next Year-31.52%
Revenue Next 2Y-49.3%
Revenue Next 3Y-17.74%
Revenue Next 5Y31.91%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

EH is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EH's earnings are expected to decrease with -121.71% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-226.55%
EPS Next 3Y-121.71%

0

5. Dividend

5.1 Amount

No dividends for EH!.
Industry RankSector Rank
Dividend Yield N/A

EHANG HOLDINGS LTD-SPS ADR

NASDAQ:EH (12/20/2024, 8:06:46 PM)

After market: 15.13 +0.12 (+0.8%)

15.01

+0.99 (+7.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-18 2024-11-18/bmo
Earnings (Next)N/A N/A
Inst Owners19.92%
Inst Owner Change-4.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap953.97M
Analysts84.44
Price Target23.25 (54.9%)
Short Float %13.33%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.4%
Min EPS beat(2)60.97%
Max EPS beat(2)77.82%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.48%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)20.82%
Revenue beat(4)3
Avg Revenue beat(4)86.28%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)192.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.86%
PT rev (3m)-6.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)12.64%
EPS NY rev (3m)48.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.79%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 44.36
P/FCF N/A
P/OCF N/A
P/B 32.68
P/tB 33.09
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.34
BVpS0.46
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.91%
ROE -130.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.27%
FCFM N/A
ROA(3y)-56.95%
ROA(5y)-41.16%
ROE(3y)-166.55%
ROE(5y)-111.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.85%
GM growth 5Y4.79%
F-ScoreN/A
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.69
Altman-Z 5.08
F-ScoreN/A
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)141.86%
Cap/Depr(5y)127.63%
Cap/Sales(3y)22.18%
Cap/Sales(5y)14.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.33%
EPS Next Y-551.53%
EPS Next 2Y-226.55%
EPS Next 3Y-121.71%
EPS Next 5Y33.54%
Revenue 1Y (TTM)47.84%
Revenue growth 3Y78.44%
Revenue growth 5YN/A
Sales Q2Q%365.53%
Revenue Next Year-31.52%
Revenue Next 2Y-49.3%
Revenue Next 3Y-17.74%
Revenue Next 5Y31.91%
EBIT growth 1Y9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.84%
EBIT Next 3Y41.2%
EBIT Next 5YN/A
FCF growth 1Y47.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.03%
OCF growth 3YN/A
OCF growth 5YN/A